Product | Indication | Preclinical | Phase One | Phase Two | Phase Three |
Retinal Disease Programs | |||||
KIO-301 (Intravitreal) | Retinitis Pigmentosa |
|
|
|
|
Choroideremia |
|
|
|
|
|
Stargardt Disease |
|
|
|
|
|
KIO-104 (Intravitreal) | Posterior Non-Infectious Uveitis |
|
|
|
|